Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study [PDF]
Journal of the Anus, Rectum and Colon, 2023 Objectives: This study aimed to compare the short and long-term outcomes of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer
Shinya Yoshida +7 more
doaj +3 more sources
Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid [PDF]
The Journal of Pathology: Clinical Research, 2021 Tumor‐derived cell‐free DNA (cfDNA) is an emerging biomarker for guiding the personalized treatment of patients with metastatic colorectal cancer (CRC). While patients with CRC liver metastases (CRC‐LM) have relatively high levels of plasma cfDNA, little
Iris Van't Erve +18 more
semanticscholar +2 more sources
World Journal of Surgical OncologyBackground Cytoreductive surgery and chemotherapy reportedly improve the prognosis of patients with metachronous peritoneal metastases. However, the types of peritoneal metastases indicated for cytoreductive surgery remains unclear.
Emi Ota +6 more
doaj +2 more sources
Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer
Pancreas, 2021 Supplemental digital content is available in the text. Objective The aim of the study was to gain insight in the incidence, treatment, and survival of patients with synchronous pancreatic peritoneal metastases.
A. Rijken +7 more
semanticscholar +3 more sources
Characterization of collagen profile in peritoneal metastases of colorectal cancer [PDF]
Scientific ReportsThe tumor microenvironment (TME) plays a critical role in cancer progression and response to treatment. In colorectal cancer (CRC), a collagen-rich extracellular matrix (ECM) is a well-established feature of primary tumors and liver metastases.
P. Villarejo-Campos +8 more
doaj +2 more sources
Long-term control of peritoneal metastases following claudin 18.2-targeted CAR T-Cell therapy in advanced gastric cancer [PDF]
Journal of Hematology & OncologyGastric cancer with peritoneal metastasis has a poor prognosis and limited treatment options. Claudin 18.2 (CLDN18.2) CAR T therapy has shown activity in advanced gastric cancer, but its role in peritoneal disease remains insufficiently characterized ...
Chang Liu +11 more
doaj +2 more sources
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer
Journal of Clinical Medicine, 2021 Common knowledge would suggest that regional treatments for peritoneal metastases from gastric cancer would not be successful [...].
M. Kwong, C. Ihemelandu, P. Sugarbaker
semanticscholar +2 more sources
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma, with or without peritoneal metastases: a post-hoc analysis on RATIONALE-305 studyResearch in context [PDF]
EClinicalMedicineSummary: Background: While immunotherapy plus chemotherapy is the current first-line standard for gastric or gastroesophageal junction adenocarcinoma (GC/GEJC), subgroup analyses in patients with peritoneal metastasis are limited and show inconsistent ...
Miao-Zhen Qiu +13 more
doaj +2 more sources
An Unusual Case of Isolated Peritoneal Metastases from Lung Adenocarcinoma
Case Reports in Oncology, 2014 Introduction: Peritoneal metastases from lung cancer are a rare event. In this paper, we report the case of a patient with adenocarcinoma of the lungs who had isolated peritoneal metastases at the time of diagnosis.
Aziz Bazine +5 more
doaj +2 more sources
Eurasian Journal of Medicine, 2012 Objective: The purpose of our study was to evaluate the utility of the apparent diffusion coefficient (ADC) value measurement in the diagnosis of peritoneal metastases on diffusion weighted magnetic resonance imaging.
Mehmet Ruhi Onur +4 more
doaj +1 more source